Profile data is unavailable for this security.
About the company
PT Millennium Pharmacon International Tbk is an Indonesia-based company primarily engaged in distributing pharmaceutical products. The Company’s segments include Prescription Medicine, Medical Devices, and Non-prescription Medicine. The Company’s products include Atangin JRG liquid, Tissue Lovers for Man, Antangin Black Seed, OB Herbs, Safe Care Aromatherapy, Lansoprazole Nulab, MMPSG065 Metra Surgical Glove POW 6.5, and 2TRGPSG070 Tro-Sensosurge Sterile Glove 7.0 pcs. A Tangin Jrg Liquid is an herbal syrup for colds with the main ingredients ginger, royal jelly and ginseng. Tissue Lovers For Man is a refreshing wet wipe, which cleanses the skin of sensitive areas. Antangin Habbatussauda is an herbal syrup containing black seed, meniran and ginger. The Company distributes its products to Java, Bali, Sumatera, Kalimantan and Sulawesi islands.
- Revenue in IDR (TTM)3.36tn
- Net income in IDR33.09bn
- Incorporated1953
- Employees1.15k
- LocationMillennium Pharmacon International Tbk PTPanin Bank Centre 9th floorJl. Jenderal Sudirman, SenayanJAKARTA SELATAN 12220IndonesiaIDN
- Phone+62 2 127085961
- Fax+62 2 127085958
- Websitehttps://www.mpi-indonesia.co.id/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Zeo Scientifix Inc | 75.13bn | -92.90bn | 118.97bn | 23.00 | -- | -- | -- | 1.58 | -0.8249 | -0.8249 | 0.6729 | -0.2462 | 1.38 | 1.88 | 30.66 | 201,828.30 | -170.08 | -371.43 | -- | -- | 87.89 | 88.28 | -123.65 | -200.71 | 0.4017 | -14.47 | -- | -- | -29.78 | 36.43 | 21.47 | -- | 40.91 | -- |
| China Healthwise Holdings Ltd | 303.10bn | -278.75bn | 127.69bn | 100.00 | -- | 14.02 | -- | 0.4213 | -0.1746 | -0.1746 | 0.1899 | 0.0057 | 0.6691 | 1.55 | 25.84 | 1,463,170.00 | -61.54 | -- | -122.54 | -- | 41.21 | -- | -91.96 | -- | 0.585 | -0.2552 | 0.9612 | -- | 3.00 | -- | -147.92 | -- | -- | -- |
| New Ray Medicine International Holding | 103.90bn | -45.93bn | 131.61bn | 23.00 | -- | 0.1323 | -- | 1.27 | -0.0133 | -0.0133 | 0.03 | 0.2873 | 0.0973 | 1.17 | 0.3658 | 2,180,609.00 | -4.30 | -6.86 | -4.36 | -7.07 | 22.61 | 4.24 | -44.20 | -29.81 | 62.47 | -- | 0.0006 | -- | -44.13 | -33.03 | 71.56 | -- | -64.84 | -- |
| Pa Shun International Holdings Ltd | 289.70bn | 5.26bn | 134.44bn | 90.00 | 25.61 | -- | 10.62 | 0.4641 | 0.0017 | 0.0017 | 0.0948 | -0.085 | 0.7555 | 12.45 | 5.50 | 1,553,874.00 | 1.37 | -41.00 | -- | -68.51 | 22.74 | 7.03 | 1.82 | -61.22 | 0.4799 | 1.99 | 3.33 | -- | 80.30 | -30.89 | 105.42 | -- | -- | -- |
| China Ever Grand Financl Lasng Gp Co Ltd | 109.18bn | -83.71bn | 139.81bn | 62.00 | -- | 0.149 | -- | 1.28 | -0.024 | -0.0229 | 0.0312 | 0.2684 | 0.0808 | 2.13 | 3.59 | 850,032.30 | -6.20 | -9.34 | -8.31 | -16.17 | 33.72 | 8.95 | -76.67 | -140.71 | 1.59 | -227.39 | 0.00 | -- | -26.54 | -10.25 | -27.68 | -- | -22.87 | -- |
| China NT Pharma Group Company Ltd | 16.49bn | -74.96bn | 158.65bn | 16.00 | -- | -- | -- | 9.62 | -0.0183 | -0.0784 | 0.0038 | -0.1389 | 0.011 | 5.87 | 0.3316 | 497,433.40 | -5.02 | -12.34 | -- | -163.52 | 710.06 | -- | -454.67 | -128.28 | 0.0185 | -- | 64.15 | -- | -- | -58.12 | 33.07 | -- | -- | -- |
| Bio Essence Corp | 8.93bn | -12.99bn | 159.95bn | 12.00 | -- | -- | -- | 17.92 | -0.0223 | -0.027 | 0.0156 | -0.0437 | 0.262 | 1.69 | 27.11 | 45,959.17 | -38.13 | -46.34 | -- | -- | 50.31 | 33.89 | -145.52 | -111.21 | 0.3017 | -45.50 | 5.31 | -- | -11.27 | -10.94 | -52.03 | -- | -48.19 | -- |
| Bio-Gate AG | 114.67bn | -25.25bn | 163.69bn | 38.00 | -- | 2.48 | -- | 1.43 | -0.1693 | -0.1693 | 0.7689 | 0.4109 | 1.33 | 1.38 | 9.27 | 200,144.80 | -29.34 | -26.41 | -40.85 | -36.33 | 65.19 | 62.59 | -22.02 | -21.21 | 1.39 | -38.49 | 0.00 | -- | -3.94 | 9.35 | -231.88 | -- | -4.73 | -- |
| Millennium Pharmacon Internationl Tbk PT | 3.36tn | 33.09bn | 175.81bn | 1.15k | 5.31 | 0.6331 | 3.38 | 0.0523 | 25.97 | 25.97 | 2,640.12 | 217.99 | 2.21 | 5.72 | 5.58 | 2,914,660,000.00 | 2.18 | 1.21 | 10.32 | 5.62 | 8.69 | 8.40 | 0.9835 | 0.5213 | 0.7085 | 1.84 | 0.7189 | -- | 5.08 | 7.20 | 35.25 | 11.22 | 27.63 | -- |
| Cosmos Health Inc | 802.59bn | -694.49bn | 185.18bn | 102.00 | -- | 0.1985 | -- | 0.2307 | -7.92 | -7.92 | 5.07 | 3.43 | 0.8466 | 9.26 | 1.78 | 486,159.40 | -26.65 | -18.81 | -54.15 | -75.34 | 7.17 | 11.90 | -31.48 | -13.96 | 1.79 | -16.85 | 0.1831 | -- | -10.48 | 10.90 | -310.05 | -- | 47.25 | -- |
| Liberta Co Ltd | 746.63bn | 11.73bn | 218.15bn | 118.00 | 18.37 | 1.25 | 8.29 | 0.2922 | 37.45 | 37.45 | 2,385.49 | 548.78 | 1.31 | 3.31 | 5.73 | 60,066,140.00 | 2.06 | 3.75 | 3.79 | 6.42 | 40.26 | 41.81 | 1.58 | 2.37 | 0.991 | 22.84 | 0.603 | 35.67 | 6.77 | 9.76 | -2.77 | -12.85 | 23.12 | -- |
| BIMI Holdings Inc | 204.46bn | -170.24bn | 228.75bn | 296.00 | 0.7228 | 0.7971 | -- | 1.12 | 1.44 | 1.59 | 2.63 | 1.30 | 0.3713 | 1.81 | 2.25 | 42,677.87 | -31.04 | -38.59 | -77.82 | -88.93 | 40.30 | 34.59 | -83.60 | -135.61 | 0.8572 | -24.66 | 0.1134 | -- | -44.51 | 6.82 | 37.56 | -- | -- | -- |
Data as of May 03 2024. Currency figures normalised to Millennium Pharmacon International Tbk PT's reporting currency: Indonesian Rupiah IDR
